Drug silica nanocomposite: preparation, characterization and skin permeation studies.
The aim of this work was to evaluate silica nanocomposites as topical drug delivery systems for the model drug, caffeine. Preparation, characterization, and skin permeation properties of caffeine-silica nanocomposites are described. Caffeine was loaded into the nanocomposites by grinding the drug with mesoporous silica in a ball mill up to 10 h and the efficiency of the process was studied by XRPD. Formulations were characterized by several methods that include FTIR, XRPD, SEM and TEM. The successful loading of caffeine was demonstrated by XRPD and FTIR. Morphology was studied by SEM that showed particle size reduction while TEM demonstrated formation of both core-shell and multilayered caffeine-silica structures. Solid-state NMR spectra excluded chemical interactions between caffeine and silica matrix, thus confirming that no solid state reactions occurred during the grinding process. Influence of drug inclusion in silica nanocomposite on the in vitro caffeine diffusion into and through the skin was investigated in comparison with a caffeine gel formulation (reference), using newborn pig skin and vertical Franz diffusion cells. Results from the in vitro skin permeation experiments showed that inclusion into the nanocomposite reduced and delayed caffeine permeation from the silica nanocomposite in comparison with the reference, independently from the amount of the tested formulation.
Università degli Studi di Cagliari, Dipartimento Scienze Chimiche, Monserrato (Ca), Italy. martina.pilloni@gmail.com
Martina
M
Pilloni
Guido
G
Ennas
Mariano
M
Casu
Anna Maria
AM
Fadda
Francesca
F
Frongia
Francesca
F
Marongiu
Roberta
R
Sanna
Alessandra
A
Scano
Donatella
D
Valenti
Chiara
C
Sinico
D000818:Animals; D000831:Animals, Newborn; D002626:Chemistry, Pharmaceutical / Q000379:methods*; D053761:Nanocomposites / Q000008:administration & dosage / Q000737:chemistry*; D009924:Organ Culture Techniques; D012822:Silicon Dioxide / Q000138:chemical synthesis* / Q000493:pharmacokinetics; D012867:Skin / Q000187:drug effects* / Q000378:metabolism; D012869:Skin Absorption / Q000187:drug effects / Q000502:physiology; D013552:Swine
D012822:Silicon Dioxide